IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance
DH Munn, AL Mellor - Trends in immunology, 2016 - cell.com
Indoleamine 2, 3-dioxygenase (IDO) has immunoregulatory roles associated with tryptophan
metabolism. These include counter-regulation (controlling inflammation) and acquired …
metabolism. These include counter-regulation (controlling inflammation) and acquired …
Indoleamine 2, 3 dioxygenase and metabolic control of immune responses
DH Munn, AL Mellor - Trends in immunology, 2013 - cell.com
Sustained access to nutrients is a fundamental biological need, especially for proliferating
cells, and controlling nutrient supply is an ancient strategy to regulate cellular responses to …
cells, and controlling nutrient supply is an ancient strategy to regulate cellular responses to …
CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential
CH Koh, S Lee, M Kwak, BS Kim… - Experimental & Molecular …, 2023 - nature.com
CD8 T cells play crucial roles in immune surveillance and defense against infections and
cancer. After encountering antigenic stimulation, naïve CD8 T cells differentiate and acquire …
cancer. After encountering antigenic stimulation, naïve CD8 T cells differentiate and acquire …
The complex role of regulatory T cells in immunity and aging
L Rocamora-Reverte, FL Melzer, R Würzner… - Frontiers in …, 2021 - frontiersin.org
The immune system is a tightly regulated network which allows the development of defense
mechanisms against foreign antigens and tolerance toward self-antigens. Regulatory T cells …
mechanisms against foreign antigens and tolerance toward self-antigens. Regulatory T cells …
Targeting the indoleamine 2, 3-dioxygenase pathway in cancer
Tumor cells escape the immune surveillance system of the host through a process called
immune tolerance. Immunotherapy targets molecules that serve as checks and balances in …
immune tolerance. Immunotherapy targets molecules that serve as checks and balances in …
[HTML][HTML] The rationale of indoleamine 2, 3-dioxygenase inhibition for cancer therapy
L Brochez, I Chevolet, V Kruse - European journal of cancer, 2017 - Elsevier
Abstract Indoleamine 2, 3-dioxygenase (IDO, also referred to as IDO1) has been
demonstrated to be a normal endogenous mechanism of acquired peripheral immune …
demonstrated to be a normal endogenous mechanism of acquired peripheral immune …
Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
Y Liu, X Liang, X Yin, J Lv, K Tang, J Ma, T Ji… - Nature …, 2017 - nature.com
Interactions with the immune system may lead tumorigenic cells into dormancy. However,
the underlying molecular mechanism is poorly understood. Using a 3D fibrin gel model, we …
the underlying molecular mechanism is poorly understood. Using a 3D fibrin gel model, we …
CD8+ Tregs revisited: A heterogeneous population with different phenotypes and properties
V Niederlova, O Tsyklauri, T Chadimova… - European journal of …, 2021 - Wiley Online Library
Regulatory T cells (Tregs) play a key role in the peripheral self‐tolerance and preventing
autoimmunity. While classical CD4+ Foxp3+ Tregs are well established, their CD8+ …
autoimmunity. While classical CD4+ Foxp3+ Tregs are well established, their CD8+ …
Trial watch: IDO inhibitors in cancer therapy
Indoleamine 2, 3-dioxigenase 1 (IDO1) is the main enzyme that catalyzes the first, rate-
limiting step of the so-called “kynurenine pathway”, ie, the metabolic cascade that converts …
limiting step of the so-called “kynurenine pathway”, ie, the metabolic cascade that converts …
Effector mechanisms of rejection
A Moreau, E Varey, I Anegon… - Cold Spring …, 2013 - perspectivesinmedicine.cshlp.org
Organ transplantation appears today to be the best alternative to replace the loss of vital
organs induced by various diseases. Transplants can, however, also be rejected by the …
organs induced by various diseases. Transplants can, however, also be rejected by the …